IRWD
Price
$1.32
Change
-$0.00 (-0.00%)
Updated
Aug 29, 04:03 PM (EDT)
Capitalization
214.41M
69 days until earnings call
PRGO
Price
$23.69
Change
-$0.07 (-0.29%)
Updated
Aug 29, 04:15 PM (EDT)
Capitalization
3.27B
68 days until earnings call
Interact to see
Advertisement

IRWD vs PRGO

Header iconIRWD vs PRGO Comparison
Open Charts IRWD vs PRGOBanner chart's image
Ironwood Pharmaceuticals
Price$1.32
Change-$0.00 (-0.00%)
Volume$4.42K
Capitalization214.41M
Perrigo
Price$23.69
Change-$0.07 (-0.29%)
Volume$200
Capitalization3.27B
IRWD vs PRGO Comparison Chart in %
Loading...
IRWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRWD vs. PRGO commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRWD is a Buy and PRGO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (IRWD: $1.32 vs. PRGO: $23.76)
Brand notoriety: IRWD and PRGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: IRWD: 61% vs. PRGO: 99%
Market capitalization -- IRWD: $214.41M vs. PRGO: $3.27B
IRWD [@Pharmaceuticals: Generic] is valued at $214.41M. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $3.27B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRWD’s FA Score shows that 0 FA rating(s) are green whilePRGO’s FA Score has 1 green FA rating(s).

  • IRWD’s FA Score: 0 green, 5 red.
  • PRGO’s FA Score: 1 green, 4 red.
According to our system of comparison, both IRWD and PRGO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRWD’s TA Score shows that 4 TA indicator(s) are bullish while PRGO’s TA Score has 6 bullish TA indicator(s).

  • IRWD’s TA Score: 4 bullish, 4 bearish.
  • PRGO’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, PRGO is a better buy in the short-term than IRWD.

Price Growth

IRWD (@Pharmaceuticals: Generic) experienced а +11.86% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was +1.41% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.16%. For the same industry, the average monthly price growth was +68.10%, and the average quarterly price growth was +81.57%.

Reported Earning Dates

IRWD is expected to report earnings on Nov 06, 2025.

PRGO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRGO($3.27B) has a higher market cap than IRWD($214M). PRGO has higher P/E ratio than IRWD: PRGO (2818.00) vs IRWD (92.69). PRGO YTD gains are higher at: -5.632 vs. IRWD (-70.203). PRGO has higher annual earnings (EBITDA): 612M vs. IRWD (79.6M). PRGO has more cash in the bank: 454M vs. IRWD (92.9M). IRWD has less debt than PRGO: IRWD (599M) vs PRGO (3.65B). PRGO has higher revenues than IRWD: PRGO (4.33B) vs IRWD (309M).
IRWDPRGOIRWD / PRGO
Capitalization214M3.27B7%
EBITDA79.6M612M13%
Gain YTD-70.203-5.6321,247%
P/E Ratio92.692818.003%
Revenue309M4.33B7%
Total Cash92.9M454M20%
Total Debt599M3.65B16%
FUNDAMENTALS RATINGS
IRWD vs PRGO: Fundamental Ratings
IRWD
PRGO
OUTLOOK RATING
1..100
222
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3883
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (33) in the Pharmaceuticals Other industry is somewhat better than the same rating for IRWD (80). This means that PRGO’s stock grew somewhat faster than IRWD’s over the last 12 months.

PRGO's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as IRWD (100). This means that PRGO’s stock grew similarly to IRWD’s over the last 12 months.

PRGO's SMR Rating (100) in the Pharmaceuticals Other industry is in the same range as IRWD (100). This means that PRGO’s stock grew similarly to IRWD’s over the last 12 months.

IRWD's Price Growth Rating (38) in the Pharmaceuticals Other industry is somewhat better than the same rating for PRGO (83). This means that IRWD’s stock grew somewhat faster than PRGO’s over the last 12 months.

IRWD's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as PRGO (100). This means that IRWD’s stock grew similarly to PRGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IRWDPRGO
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 8 days ago
67%
Bullish Trend 10 days ago
61%
Declines
ODDS (%)
Bearish Trend 15 days ago
80%
Bearish Trend 4 days ago
65%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
58%
Aroon
ODDS (%)
Bullish Trend 2 days ago
48%
Bullish Trend 2 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
IRWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MWOHX64.37N/A
N/A
MFS Global Growth R3
VHCOX90.88N/A
N/A
Vanguard Capital Opportunity Inv
GLNKX23.74N/A
N/A
MFS Global New Discovery R2
VRMCX62.65N/A
N/A
Virtus KAR Mid-Cap Core R6
TRSZX23.22N/A
N/A
T. Rowe Price Mid-Cap Index Z

IRWD and

Correlation & Price change

A.I.dvisor tells us that IRWD and ACET have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRWD and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRWD
1D Price
Change %
IRWD100%
+4.76%
ACET - IRWD
30%
Poorly correlated
+0.40%
PRGO - IRWD
29%
Poorly correlated
-0.54%
ASRT - IRWD
26%
Poorly correlated
+5.32%
ELAN - IRWD
24%
Poorly correlated
-0.22%
HROW - IRWD
24%
Poorly correlated
+0.52%
More

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with ORGO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
-0.54%
ORGO - PRGO
47%
Loosely correlated
+5.79%
EOLS - PRGO
43%
Loosely correlated
-0.79%
AMRX - PRGO
39%
Loosely correlated
+2.03%
PBH - PRGO
35%
Loosely correlated
+0.45%
ANIP - PRGO
32%
Poorly correlated
+0.71%
More